Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtua...
Gespeichert in:
Veröffentlicht in: | Journal of medicinal chemistry 2017-11, Vol.60 (21), p.8982-8988 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8988 |
---|---|
container_issue | 21 |
container_start_page | 8982 |
container_title | Journal of medicinal chemistry |
container_volume | 60 |
creator | Krüger, Dennis M Glas, Adrian Bier, David Pospiech, Nicole Wallraven, Kerstin Dietrich, Laura Ottmann, Christian Koch, Oliver Hennig, Sven Grossmann, Tom N |
description | Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts. |
doi_str_mv | 10.1021/acs.jmedchem.7b01221 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5682607</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1951564196</sourcerecordid><originalsourceid>FETCH-LOGICAL-a449t-a657029002e3f45155f7c69aa8814201c1fd01086cddc299bf002d57d643f9193</originalsourceid><addsrcrecordid>eNp9Uctu1DAUtRCIDqV_UFVZssn0Xsdx4g0SlEIr9SXRri2PY3dcZezBdpC66z_wh3wJLjOtYNOVr3QePjqHkH2EOQLFQ6XT_G5lBr00q3m3AKQUX5EZthRq1gN7TWYAlNaU02aHvEvpDgAapM1bskMF0B47nBH7PcdJ5yma-rNKZqi-mORufRVsdRF87VWB1FidKx2Dvtej09WVWWc3mFRdL1WuTv3SLVyurmLIxvnfD7-2V0GyiUpnF3x6T95YNSazt313yc3X4-ujk_rs8tvp0aezWjEmcq1420EJB9Q0lrXYtrbTXCjV98gooEY7AELP9TBoKsTCFurQdgNnjRUoml3yceO7nhaP3RifS3y5jm6l4r0Mysn_Ee-W8jb8lC3vKYeuGHzYGsTwYzIpy5VL2oyj8iZMSaIoqThDwQuVbailmpSisc_fIMjHiWSZSD5NJLcTFdnBvxGfRU-bFAJsCH_lYYq-NPay5x_DiKMW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1951564196</pqid></control><display><type>article</type><title>Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Krüger, Dennis M ; Glas, Adrian ; Bier, David ; Pospiech, Nicole ; Wallraven, Kerstin ; Dietrich, Laura ; Ottmann, Christian ; Koch, Oliver ; Hennig, Sven ; Grossmann, Tom N</creator><creatorcontrib>Krüger, Dennis M ; Glas, Adrian ; Bier, David ; Pospiech, Nicole ; Wallraven, Kerstin ; Dietrich, Laura ; Ottmann, Christian ; Koch, Oliver ; Hennig, Sven ; Grossmann, Tom N</creatorcontrib><description>Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.7b01221</identifier><identifier>PMID: 29028171</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Amino Acids ; Animals ; Binding Sites ; Crystallography, X-Ray ; Drug Design ; Humans ; Molecular Docking Simulation ; Peptide Library ; Peptides, Cyclic - chemistry ; Peptides, Cyclic - pharmacology ; Protein Binding - drug effects ; Protein Interaction Domains and Motifs - drug effects ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 2017-11, Vol.60 (21), p.8982-8988</ispartof><rights>Copyright © 2017 American Chemical Society</rights><rights>Copyright © 2017 American Chemical Society 2017 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a449t-a657029002e3f45155f7c69aa8814201c1fd01086cddc299bf002d57d643f9193</citedby><cites>FETCH-LOGICAL-a449t-a657029002e3f45155f7c69aa8814201c1fd01086cddc299bf002d57d643f9193</cites><orcidid>0000-0001-9228-217X ; 0000-0002-8297-6845 ; 0000-0003-0179-4116 ; 0000-0001-7315-0315</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b01221$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01221$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,780,784,885,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29028171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krüger, Dennis M</creatorcontrib><creatorcontrib>Glas, Adrian</creatorcontrib><creatorcontrib>Bier, David</creatorcontrib><creatorcontrib>Pospiech, Nicole</creatorcontrib><creatorcontrib>Wallraven, Kerstin</creatorcontrib><creatorcontrib>Dietrich, Laura</creatorcontrib><creatorcontrib>Ottmann, Christian</creatorcontrib><creatorcontrib>Koch, Oliver</creatorcontrib><creatorcontrib>Hennig, Sven</creatorcontrib><creatorcontrib>Grossmann, Tom N</creatorcontrib><title>Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts.</description><subject>Amino Acids</subject><subject>Animals</subject><subject>Binding Sites</subject><subject>Crystallography, X-Ray</subject><subject>Drug Design</subject><subject>Humans</subject><subject>Molecular Docking Simulation</subject><subject>Peptide Library</subject><subject>Peptides, Cyclic - chemistry</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Protein Binding - drug effects</subject><subject>Protein Interaction Domains and Motifs - drug effects</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Uctu1DAUtRCIDqV_UFVZssn0Xsdx4g0SlEIr9SXRri2PY3dcZezBdpC66z_wh3wJLjOtYNOVr3QePjqHkH2EOQLFQ6XT_G5lBr00q3m3AKQUX5EZthRq1gN7TWYAlNaU02aHvEvpDgAapM1bskMF0B47nBH7PcdJ5yma-rNKZqi-mORufRVsdRF87VWB1FidKx2Dvtej09WVWWc3mFRdL1WuTv3SLVyurmLIxvnfD7-2V0GyiUpnF3x6T95YNSazt313yc3X4-ujk_rs8tvp0aezWjEmcq1420EJB9Q0lrXYtrbTXCjV98gooEY7AELP9TBoKsTCFurQdgNnjRUoml3yceO7nhaP3RifS3y5jm6l4r0Mysn_Ee-W8jb8lC3vKYeuGHzYGsTwYzIpy5VL2oyj8iZMSaIoqThDwQuVbailmpSisc_fIMjHiWSZSD5NJLcTFdnBvxGfRU-bFAJsCH_lYYq-NPay5x_DiKMW</recordid><startdate>20171109</startdate><enddate>20171109</enddate><creator>Krüger, Dennis M</creator><creator>Glas, Adrian</creator><creator>Bier, David</creator><creator>Pospiech, Nicole</creator><creator>Wallraven, Kerstin</creator><creator>Dietrich, Laura</creator><creator>Ottmann, Christian</creator><creator>Koch, Oliver</creator><creator>Hennig, Sven</creator><creator>Grossmann, Tom N</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9228-217X</orcidid><orcidid>https://orcid.org/0000-0002-8297-6845</orcidid><orcidid>https://orcid.org/0000-0003-0179-4116</orcidid><orcidid>https://orcid.org/0000-0001-7315-0315</orcidid></search><sort><creationdate>20171109</creationdate><title>Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions</title><author>Krüger, Dennis M ; Glas, Adrian ; Bier, David ; Pospiech, Nicole ; Wallraven, Kerstin ; Dietrich, Laura ; Ottmann, Christian ; Koch, Oliver ; Hennig, Sven ; Grossmann, Tom N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a449t-a657029002e3f45155f7c69aa8814201c1fd01086cddc299bf002d57d643f9193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Amino Acids</topic><topic>Animals</topic><topic>Binding Sites</topic><topic>Crystallography, X-Ray</topic><topic>Drug Design</topic><topic>Humans</topic><topic>Molecular Docking Simulation</topic><topic>Peptide Library</topic><topic>Peptides, Cyclic - chemistry</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Protein Binding - drug effects</topic><topic>Protein Interaction Domains and Motifs - drug effects</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krüger, Dennis M</creatorcontrib><creatorcontrib>Glas, Adrian</creatorcontrib><creatorcontrib>Bier, David</creatorcontrib><creatorcontrib>Pospiech, Nicole</creatorcontrib><creatorcontrib>Wallraven, Kerstin</creatorcontrib><creatorcontrib>Dietrich, Laura</creatorcontrib><creatorcontrib>Ottmann, Christian</creatorcontrib><creatorcontrib>Koch, Oliver</creatorcontrib><creatorcontrib>Hennig, Sven</creatorcontrib><creatorcontrib>Grossmann, Tom N</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krüger, Dennis M</au><au>Glas, Adrian</au><au>Bier, David</au><au>Pospiech, Nicole</au><au>Wallraven, Kerstin</au><au>Dietrich, Laura</au><au>Ottmann, Christian</au><au>Koch, Oliver</au><au>Hennig, Sven</au><au>Grossmann, Tom N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2017-11-09</date><risdate>2017</risdate><volume>60</volume><issue>21</issue><spage>8982</spage><epage>8988</epage><pages>8982-8988</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>29028171</pmid><doi>10.1021/acs.jmedchem.7b01221</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9228-217X</orcidid><orcidid>https://orcid.org/0000-0002-8297-6845</orcidid><orcidid>https://orcid.org/0000-0003-0179-4116</orcidid><orcidid>https://orcid.org/0000-0001-7315-0315</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-2623 |
ispartof | Journal of medicinal chemistry, 2017-11, Vol.60 (21), p.8982-8988 |
issn | 0022-2623 1520-4804 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5682607 |
source | MEDLINE; American Chemical Society Journals |
subjects | Amino Acids Animals Binding Sites Crystallography, X-Ray Drug Design Humans Molecular Docking Simulation Peptide Library Peptides, Cyclic - chemistry Peptides, Cyclic - pharmacology Protein Binding - drug effects Protein Interaction Domains and Motifs - drug effects Structure-Activity Relationship |
title | Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T09%3A22%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure-Based%20Design%20of%20Non-natural%20Macrocyclic%20Peptides%20That%20Inhibit%20Protein%E2%80%93Protein%20Interactions&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Kru%CC%88ger,%20Dennis%20M&rft.date=2017-11-09&rft.volume=60&rft.issue=21&rft.spage=8982&rft.epage=8988&rft.pages=8982-8988&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.7b01221&rft_dat=%3Cproquest_pubme%3E1951564196%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1951564196&rft_id=info:pmid/29028171&rfr_iscdi=true |